Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

Pfizer's headquarters

People walk by the Pfizer world headquarters in New York on November 9, 2020. (Photo: Kena Betancur/AFP via Getty Images)

Insulated From Patent Waivers, Pfizer and Moderna Hike Vaccine Prices

"Capitalism never fails to not surprise," wrote one observer.

Julia Conley

With some of the world's wealthiest countries continuing to oppose temporary patent waivers for Covid-19 vaccines in order to more rapidly deploy life-saving shots worldwide, pharmaceutical giants Pfizer and Moderna have raised the price for European Union orders.
 
In its new supply contract with the E.U., Pfizer named a price of more than $23 per dose, up nearly 25% from about $18 on earlier purchases. Moderna said in its latest agreement that its mRNA vaccine will cost one-tenth more than its previous price, charging $25.50 per dose.

"Our governments are complicit in this heist by pharma and companies across the board in other sectors. It's the system they helped create."
—Tahir Amin, intellectual property lawyer

 
The two companies plan to provide the E.U. with 2.1 billion vaccine doses until 2023, and are already expected to rake in tens of billions of dollars this year from vaccine sales.
 
"Capitalism never fails to not surprise," tweeted The New Yorker writer John Cassidy in response to reporting from the Financial Times.
 
With patent protections kept in place by the World Trade Organization (WTO) as E.U. countries including Germany, Switzerland, and the United Kingdom oppose lifting Trade-Related Aspects of Intellectual Property Rights (TRIPS) for Covid-19-related products, vaccine doses have mainly been available in wealthy countries. 
 
According to the New York Times' latest analysis, 0.3% of doses have been administered in low-income countries, leading public health experts to warn that Covid-19 will continue to mutate and dangerous, highly infectious variants like Delta will continue to emerge and spread throughout the world.
 
The companies are raising their prices "just in time for the Delta variant," one observer wrote on Twitter.
 
Pfizer and Moderna have raised their prices as Europe faces supply chain issues with the Johnson & Johnson and AstraZeneca vaccines—the latter of which has been more widely available in low-income countries—and as new studies showed higher efficacy of the mRNA vaccines compared to the cheaper shots.
 
An official involved in the price negotiations told the Financial Times that Pfizer and Moderna used the "usual pharma rhetoric" in discussing the price hikes.
 
"Vaccines work so they increased the 'value,'" the official said.
 
With the two companies continuing to sell most of its supply to high-income countries, Pfizer's sales are now expected to reach $56 billion and Moderna's are expected to reach $30 billion. 
 
"E.U., care to rethink your position on a patent waiver?," tweeted Nick Dearden, director of Global Justice Now, which has been calling for the WTO to lift patent protections for Covid-19 vaccines for months.
 
Intellectual property lawyer Tahir Amin wrote on social media that lifting patent protections for vaccines, as South African and Indian WTO representatives first proposed last year, would suspend the tool "that enables and supports this monopoly" controlled by Big Pharma.
 
"Our governments are complicit in this heist by pharma and companies across the board in other sectors," Amin said.

Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

This is the world we live in. This is the world we cover.

Because of people like you, another world is possible. There are many battles to be won, but we will battle them together—all of us. Common Dreams is not your normal news site. We don't survive on clicks. We don't want advertising dollars. We want the world to be a better place. But we can't do it alone. It doesn't work that way. We need you. If you can help today—because every gift of every size matters—please do. Without Your Support We Simply Don't Exist.

Biden Decries 'Outrageous' Treatment of Haitians at Border—But Keeps Deporting Them

"I'm glad to see President Biden speak out about the mistreatment of Haitian asylum-seekers. But his administration's use of Title 42 to deny them the right to make an asylum claim is a much bigger issue."

Jessica Corbett ·


Global Peace Activists Warn of Dangers of US-Led Anti-China Pacts

"No to military alliances and preparation for catastrophic wars," anti-war campaigners from over a dozen nations write in a letter decrying the new AUKUS agreement. "Yes to peace, disarmament, justice, and the climate."

Brett Wilkins ·


PG&E Charged With 11 Felony Counts—Including Manslaughter—Over 2020 Zogg Fire

"PG&E has a history with a repeated pattern of causing wildfires that is not getting better," said Shasta County District Attorney Stephanie Bridgett. "It's only getting worse."

Brett Wilkins ·


'Hold My Pearls': Debbie Dingell Lets Marjorie Taylor Green Have It Over Abortion Rights

The Michigan Democrat engaged in a verbal altercation with the far-right Republican lawmaker from Georgia on the steps of the U.S. Capitol Building.

Jon Queally ·


Dems Who Opposed Pentagon Cuts Received Nearly 4x More Donations From Weapons Makers

The latest passage of the NDAA "is particularly strong evidence that Pentagon contractors' interests easily take precedence over national security and the public interest for too many members of Congress," said one critic.

Kenny Stancil ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo